DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
133.87
-0.82 (-0.61%)
Aug 14, 2025, 11:43 AM - Market open
DaVita Employees
DaVita had 76,000 employees as of December 31, 2024. The number of employees increased by 6,000 or 8.57% compared to the previous year.
Employees
76,000
Change (1Y)
6,000
Growth (1Y)
8.57%
Revenue / Employee
$173,175
Profits / Employee
$11,004
Market Cap
9.57B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 76,000 | 6,000 | 8.57% |
Dec 31, 2023 | 70,000 | 0 | - |
Dec 31, 2022 | 70,000 | 1,000 | 1.45% |
Dec 31, 2021 | 69,000 | 2,000 | 2.99% |
Dec 31, 2020 | 67,000 | 2,000 | 3.08% |
Dec 31, 2019 | 65,000 | -12,700 | -16.34% |
Dec 31, 2018 | 77,700 | 3,200 | 4.30% |
Dec 31, 2017 | 74,500 | 4,200 | 5.97% |
Dec 31, 2016 | 70,300 | 9,900 | 16.39% |
Dec 31, 2015 | 60,400 | 2,500 | 4.32% |
Dec 31, 2014 | 57,900 | 500 | 0.87% |
Dec 31, 2013 | 57,400 | 4,000 | 7.49% |
Dec 31, 2012 | 53,400 | 12,400 | 30.24% |
Dec 31, 2011 | 41,000 | 4,500 | 12.33% |
Dec 31, 2010 | 36,500 | 2,500 | 7.35% |
Dec 31, 2009 | 34,000 | 1,500 | 4.62% |
Dec 31, 2008 | 32,500 | 1,500 | 4.84% |
Dec 31, 2007 | 31,000 | 2,100 | 7.27% |
Dec 31, 2006 | 28,900 | 900 | 3.21% |
Dec 31, 2005 | 28,000 | 12,700 | 83.01% |
Dec 31, 2004 | 15,300 | 1,500 | 10.87% |
Dec 31, 2003 | 13,800 | 800 | 6.15% |
Dec 31, 2002 | 13,000 | 300 | 2.36% |
Dec 31, 2001 | 12,700 | 500 | 4.10% |
Dec 31, 2000 | 12,200 | -100 | -0.81% |
Dec 31, 1999 | 12,300 | 0 | - |
Dec 31, 1998 | 12,300 | 3,470 | 39.30% |
Dec 31, 1997 | 8,830 | 5,705 | 182.56% |
Dec 31, 1996 | 3,125 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DVA News
- 8 days ago - DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - DaVita beats quarterly profit on steady demand for dialysis services - Reuters
- 8 days ago - DaVita Inc. 2nd Quarter 2025 Results - PRNewsWire
- 27 days ago - DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call - PRNewsWire
- 2 months ago - 20 stocks primed for rapid growth while trading at half of Nvidia's valuation - Market Watch
- 2 months ago - DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates - PRNewsWire
- 2 months ago - DaVita: International Expansion And Buybacks Will Boost Returns - Seeking Alpha
- 3 months ago - DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering - PRNewsWire